Journal article

A targeted psychological treatment for sleep problems in young people at ultra-high risk of psychosis in England (SleepWell): a parallel group, single-blind, randomised controlled feasibility trial

Abstract:: Background Sleep disturbance is common and problematic for young people at ultra-high risk of psychosis. Sleep disruption is a contributory causal factor in the occurrence of mental health problems, including psychotic experiences, anxiety, and depression. The implication is that treating sleep problems might have additional benefits on mental health outcomes in individuals at high risk. The present study had two aims: first, to establish the feasibility and acceptability of ... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Waite, F., Černis, E., Kabir, T., Iredale, E., Johns, L., Maughan, D., Diamond, R., Seddon, R., Williams, N., Yu, L.-M., & Freeman, D. (2023). A targeted psychological treatment for sleep problems in young people at ultra-high risk of psychosis in England (SleepWell): a parallel group, single-blind, randomised controlled feasibility trial. The Lancet Psychiatry, 10(9), 706–718.

MLA Style

Waite, F, et al. “A Targeted Psychological Treatment for Sleep Problems in Young People at Ultra-High Risk of Psychosis in England (SleepWell): a Parallel Group, Single-Blind, Randomised Controlled Feasibility Trial.” The Lancet Psychiatry, vol. 10, no. 9, 2023, pp. 706–18.

Chicago Style

Waite, F, E Černis, T Kabir, et al. 2023. “A Targeted Psychological Treatment for Sleep Problems in Young People at Ultra-High Risk of Psychosis in England (SleepWell): a Parallel Group, Single-Blind, Randomised Controlled Feasibility Trial.” The Lancet Psychiatry 10 (9): 706–18.
Print

Access Document

Files:: Waite_et_al_2023_A_targeted_psychological.pdf

(Preview, Version of record, pdf, 653.1KB, Terms of use)

Publisher copy:: 10.1016/S2215-0366(23)00203-1

Authors

+ Waite, F More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Experimental Psychology
Research group:: Psychological Therapies Theme, NIHR Oxford Health Biomedical Research Centre
Role:: Author

+ Černis, E More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Experimental Psychology
Role:: Author

+ Kabir, T More by this author

Role:: Author

+ Iredale, E More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Experimental Psychology
Role:: Author

+ Johns, L More by this author

Role:: Author

More authors...

Contributors

+ SleepWell lived experience advisory group

Role:: Contributor

+ Oxford Health NHS Foundation Trust More from this funder

+ National Institute for Health Research More from this funder

Publisher:: Elsevier
Journal:: The Lancet Psychiatry More from this journal
Volume:: 10
Issue:: 9
Pages:: 706-718
Publication date:: 2023-08-07
Acceptance date:: 2023-06-07
DOI:: 10.1016/S2215-0366(23)00203-1
EISSN:: 2215-0374
ISSN:: 2215-0366

Language:: English
Keywords:: FFR
Pubs id:: 1506011
Local pid:: pubs:1506011
Deposit date:: 2023-08-08
ARK identifier:: ark:/29072/ora_9311be1762904c9a9a5ffc50e9474383

Terms of use

Copyright holder:: Waite et al.
Copyright date:: 2023
Rights statement:: © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP